Our current study, however, is the first to describe a mechanism that controls Cxcr3 ligand secretion in TME cells by a metastasis suppressor, and moreover, it is the first to address how IFNγ-induced Cxcr3 ligand expression by PMF facilitates melanoma metastasis to the peritoneum. The gene discussed is IFNG; the disease is melanoma.